GC
DBD

Guggenheim Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History

Guggenheim Capital’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,420
Closed -$25K – 2016
2022
Q3 		$25K Sell
10,420
-12,443
-54% -$41.5K ﹤0.01% 1882
2022
Q2 		$52K Buy
22,863
+10,943
+92% +$40.8K ﹤0.01% 2033
2022
Q1 		$81K Buy
11,920
+111
+0.9% +$949 ﹤0.01% 2101
2021
Q4 		$107K Buy
+11,809
New +$110K ﹤0.01% 2090
2020
Q4 		– Sell
-12,173
Closed -$93K – 2133
2020
Q3 		$93K Sell
12,173
-6,437
-35% -$47.3K ﹤0.01% 1875
2020
Q2 		$113K Buy
18,610
+8,096
+77% +$39.9K ﹤0.01% 1815
2020
Q1 		$37K Sell
10,514
-9,526
-48% -$80.7K ﹤0.01% 1806
2019
Q4 		$212K Buy
+20,040
New +$178K ﹤0.01% 1976
2018
Q4 		– Sell
-10,194
Closed -$46K – 2415
2018
Q3 		$46K Buy
+10,194
New +$74.3K ﹤0.01% 2386
2018
Q2 		– Sell
-58,140
Closed -$895K – 2669
2018
Q1 		$895K Sell
58,140
-9,782
-14% -$163K ﹤0.01% 2126
2017
Q4 		$1.11M Sell
67,922
-16,492
-20% -$319K ﹤0.01% 2018
2017
Q3 		$1.93M Sell
84,414
-25,851
-23% -$551K ﹤0.01% 1696
2017
Q2 		$3.09M Sell
110,265
-33,779
-23% -$935K 0.01% 1306
2017
Q1 		$4.42M Sell
144,044
-17,046
-11% -$481K 0.01% 1091
2016
Q4 		$4.05M Buy
161,090
+68,625
+74% +$1.62M 0.01% 1131
2016
Q3 		$2.29M Buy
92,465
+22,044
+31% +$585K 0.01% 1536
2016
Q2 		$1.75M Sell
70,421
-116,719
-62% -$3.01M 0.01% 1650
2016
Q1 		$5.41M Sell
187,140
-665,095
-78% -$17.4M 0.02% 954
2015
Q4 		$25.6M Sell
852,235
-9,751
-1% -$331K 0.07% 479
2015
Q3 		$25.7M Sell
861,986
-331,464
-28% -$10.8M 0.08% 445
2015
Q2 		$41.8M Sell
1,193,450
-219,576
-16% -$7.74M 0.1% 339
2015
Q1 		$50.1M Buy
1,413,026
+35,470
+3% +$1.2M 0.12% 248
2014
Q4 		$47.7M Buy
1,377,556
+878,806
+176% +$31M 0.12% 249
2014
Q3 		$17.6M Buy
498,750
+3,578
+0.7% +$135K 0.04% 692
2014
Q2 		$19.9M Buy
495,172
+444,577
+879% +$17.1M 0.05% 661
2014
Q1 		$2.02M Sell
50,595
-16,532
-25% -$595K 0.01% 1794
2013
Q4 		$2.21M Sell
67,127
-27,909
-29% -$870K 0.01% 1698
2013
Q3 		$2.79M Buy
95,036
+9,324
+11% +$292K 0.01% 1402
2013
Q2 		$2.89M Buy
+85,712
New +$2.65M 0.01% 1318

Other funds holding DBD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $254M AUM 16.78% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Guggenheim Capital's DBD Position: Q4 2022 in Review

Guggenheim Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2022, closing a stake of 10,420 shares — an estimated $25K sold.

Guggenheim Capital first reported a position in DBD in Q2 2013 and held it in 29 quarters. The position peaked at $50.1M in Q1 2015. 148 funds tracked by Wall St. Rank hold DBD as of Q4 2022.

  • Guggenheim Capital reported no remaining Diebold Nixdorf Incorporated position as of Q4 2022 after selling out during the quarter.
  • Guggenheim Capital sold 10,420 Diebold Nixdorf Incorporated shares in Q4 2022, an estimated $25K.
  • Guggenheim Capital first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 29 quarters.
  • Guggenheim Capital's Diebold Nixdorf Incorporated position peaked at $50.1M in Q1 2015.
  • 148 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2022.

Based on Guggenheim Capital's 13F filing for Q4 2022, filed 14 Feb 2023.